Hypoadrenocorticism (Addison's disease) is a life-threatening adrenal gland failure in dogs that is manageable with lifelong hormone replacement, but acute crises (Addisonian crises) are medical emergencies requiring immediate intervention.
Addison's disease creates a biphasic welfare challenge: the severe acute crisis and the long-term management of a condition requiring lifelong hormone replacement. The Addisonian crisis is one of the most acute welfare emergencies in veterinary medicine — dogs collapse with severe cardiovascular compromise from hyperkalaemia-induced arrhythmia, and death can occur within hours without IV fluid resuscitation and corticosteroid administration. Dogs that survive crisis and are diagnosed face a very different welfare picture: well-managed Addisonian dogs on DOCP and prednisolone are clinically indistinguishable from normal dogs, with excellent energy, appetite, and quality of life. The management challenge is consistency: stress dosing during any illness or procedure is essential and owners must understand this protocol before any veterinary visit. The DOCP injection every 25-28 days is non-negotiable — missing injections causes electrolyte deterioration that can lead to crisis. Genetic screening programmes in at-risk breeds reduce the frequency of the condition in future generations.